Cargando…
Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma
The protein kinase V-Raf murine sarcoma viral oncogene homolog B (BRAF) is an oncogenic driver and therapeutic target in melanoma. Inhibitors of BRAF (BRAFi) have shown high response rates and extended survival in melanoma patients bearing tumors that express BRAF Val600 mutations, but a vast majori...
Autores principales: | Shen, Che-Hung, Kim, Sun Hye, Trousil, Sebastian, Frederick, Dennie T., Piris, Adriano, Yuan, Ping, Cai, Li, Gu, Lei, Li, Man, Lee, Jung Hyun, Mitra, Devarati, Fisher, David E., Sullivan, Ryan J., Flaherty, Keith T., Zheng, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014622/ https://www.ncbi.nlm.nih.gov/pubmed/27500726 http://dx.doi.org/10.1038/nm.4155 |
Ejemplares similares
-
Different NIPBL requirements of cohesin-STAG1 and cohesin-STAG2
por: Alonso-Gil, Dácil, et al.
Publicado: (2023) -
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming
por: Chu, Zhaowei, et al.
Publicado: (2022) -
Cohesin Components Stag1 and Stag2 Differentially Influence Haematopoietic Mesoderm Development in Zebrafish Embryos
por: Ketharnathan, Sarada, et al.
Publicado: (2020) -
STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers
por: van der Lelij, Petra, et al.
Publicado: (2020) -
Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts
por: van der Lelij, Petra, et al.
Publicado: (2017)